NCT00055393

Bupropion in the Treatment of Pathological Gambling

Bupropion Versus Placebo in the Treatment of Pathological Gambling

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: University of Iowa · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will determine whether the drug bupropion is an effective treatment for Pathological Gambling.

Detailed description

As gambling opportunities proliferate, PG has become a major health concern. Despite its importance, few treatment options with proven efficacy exist. This study will attempt to identify an effective treatment for PG. Participants are randomly assigned to receive either bupropion or placebo for 12 weeks. Participants are assessed at baseline and at Weeks 2, 3, 4, 5, 6, 8, 10, and 12. Self administered questionnaires and interviews are used to assess participants. Follow-up assessments are made 1, 3, and 6 months after study completion.

Conditions

• Pathological Gambling

Interventions

Type	Name	Description
DRUG	Bupropion	18 subjects in this randomly controlled double blind study received bupropion.
DRUG	Placebo	21 subjects received Placebo.

Timeline

• Start date: 2002-07-01
• Primary completion: 2005-05-01
• Completion: 2006-04-01
• First posted: 2003-03-03
• Last updated: 2017-03-14

Locations

1 site across 1 country: United States